Steris (STE)
NYSEHealth CareMedical DevicesSnapshot 2026-07-08
$209.44-2.76%
Close 2026-07-08 · 1-day change
Reading STE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track STE free→NYSEHealth CareMedical DevicesSnapshot 2026-07-08
Reading STE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track STE free→QuarterlyIQ Insights · STE
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||
| Revenues | 5,935.9 | 5,935.9 | 5,459.5 | 5,138.7 | 4,536.3 | 4,223.4 | 3,107.5 | 3,030.9 | 2,782.2 |
| Total Revenues | 5,935.9 | 5,935.9 | 5,459.5 | 5,138.7 | 4,536.3 | 4,223.4 | 3,107.5 | 3,030.9 | 2,782.2 |
| Cost of Revenues | 3,309.4 | 3,309.4 | 3,056.8 | 2,920.5 | 2,555.5 | 2,340.4 | 1,764.4 | 1,710.9 | 1,606.7 |
| Gross Profit | 2,626.5 | 2,626.5 | 2,402.8 | 2,218.2 | 1,980.7 | 1,883.0 | 1,343.1 | 1,320.0 | 1,175.4 |
| Operating Expenses & Income | |||||||||
| Selling, General & Admin | 1,407.7 | 1,407.7 | 1,334.3 | 1,252.3 | 1,090.7 | 1,318.5 | 731.3 | 716.7 | 669.9 |
| R&D Expenses | 112.9 | 112.9 | 107.6 | 103.7 | 98.5 | 86.7 | 66.3 | 65.5 | 63.0 |
| Operating Income | 1,101.8 | 1,101.8 | 866.6 | 836.1 | 791.1 | 477.8 | 548.4 | 537.0 | 411.5 |
| Earnings from Continuing Operations | |||||||||
| Interest Expense | — | — | — | 144.4 | 108.0 | 89.5 | 37.2 | 40.3 | 45.0 |
| Other Non-Operating Income / Expenses | (54.4) | (54.4) | (70.4) | (133.3) | (110.8) | (111.0) | (30.8) | (38.3) | (42.0) |
| Asset Writedown | — | — | — | — | — | — | — | — | 16.2 |
| EBT, Incl. Unusual Items | 1,047.3 | 1,047.3 | 796.2 | 702.8 | 680.3 | 366.8 | 517.5 | 498.8 | 369.5 |
| Income Tax Expense | 262.2 | 262.2 | 184.7 | 149.5 | 124.1 | 82.3 | 120.7 | 90.9 | 64.4 |
| Earnings from Continuing Operations | 785.1 | 785.1 | 611.6 | 553.3 | 556.2 | 284.5 | — | — | — |
| Net Income | |||||||||
| Minority Interest | 2.8 | 2.8 | 1.4 | 1.8 | (1.2) | (1.0) | (0.5) | 0.2 | 1.0 |
| Net Income | 782.3 | 782.3 | 614.6 | 378.2 | 107.0 | 243.9 | 397.4 | 407.7 | 304.1 |
| Per Share | |||||||||
| Basic EPS | — | 7.97 | 6.24 | 3.83 | 1.07 | 2.50 | 4.66 | 4.81 | 3.59 |
| Diluted EPS | — | 7.93 | 6.20 | 3.81 | 1.07 | 2.48 | 4.63 | 4.76 | 3.56 |
| Dividend per Share | — | 2.46 | 2.23 | 2.03 | 1.84 | 1.69 | 1.57 | 1.45 | 1.33 |
| Basic Weighted Avg Shares | — | 98.2 | 98.6 | 98.8 | 99.7 | 97.5 | 85.2 | 84.8 | 84.6 |
| Diluted Weighted Avg Shares | — | 98.7 | 99.1 | 99.4 | 100.2 | 98.3 | 85.9 | 85.6 | 85.5 |
| Supplemental | |||||||||
| EBITDA | — | 1,588.3 | 1,342.8 | 1,401.3 | 1,344.0 | 1,030.9 | 767.6 | 734.3 | 637.4 |
| EBIT | 1,101.8 | 1,101.8 | 866.6 | 836.1 | 791.1 | 477.8 | 548.4 | 537.0 | 411.5 |
| Effective Tax Rate | 25.0% | 25.0% | 23.2% | 21.3% | 18.2% | 22.4% | 23.3% | 18.2% | 17.4% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.